NEW YORK (GenomeWeb News) – Caliper Life Sciences said today it has struck a collaboration agreement under which it will bundle its LabChip systems with DiscoveRx’s G-protein-coupled receptor assays for drug research. 
 
The Hopkinton, Mass.-based company said the combined offering includes DiscoveRx’s PathHunter Beta Arrestin and cAMP Hunter assays.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.